BiotechTube
Home/Pipeline/SyqeAir Inhaler – Fibromyalgia

SyqeAir Inhaler – Fibromyalgia

Fibromyalgia

CommercialActive

Key Facts

Indication
Fibromyalgia
Phase
Commercial
Status
Active
Company
Syqe Medical

About Syqe Medical

Syqe Medical delivers precise, low‑dose medical cannabis via a patented metered‑dose inhaler for pain and other chronic conditions.

View full company profile

Therapeutic Areas

Chronic Neuropathic PainEndometriosisFibromyalgiaCrohn's DiseasePalliative CareNeurologyOncology Symptom ManagementPsychiatryEpilepsy

Other Fibromyalgia Drugs

DrugCompanyPhase
SP-104SCILEXPreclinical/Phase 1
Sequential Dialysis TechniqueHalberdDiscovery
StanzaSwing TherapeuticsApproved
Fibromyalgia StudiesPacific Clinical Research Medical GroupPhase 2/3
Fibromyalgia BiomarkersParadise GenomicsDiscovery
AXS-14Axsome TherapeuticsPhase 3
SP-104 (low-dose naltrexone DR capsules)Scilex HoldingPreclinical